Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Jinhai International Group Holdings Limited ( (HK:2225) ) has issued an announcement.
Jinhai Medical Technology Limited has announced supplementary information to its 2024 Annual Report, focusing on remedial measures for risk management and internal control systems. The company has implemented enhanced internal control policies, conducted training sessions, hired qualified staff, and sought external advice to ensure compliance with the Listing Rules. Additionally, the company provided updates on its Share Option Scheme, detailing the number of options available at the beginning and end of the financial year.
More about Jinhai International Group Holdings Limited
Jinhai Medical Technology Limited operates in the medical technology industry, focusing on the development and provision of medical products and services. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 3,842,004
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$7.81B
See more data about 2225 stock on TipRanks’ Stock Analysis page.